Journal
ONCOTARGET
Volume 7, Issue 29, Pages 45538-45546Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.9998
Keywords
CD44; the cancer genome atlas; gastric cancer; colon cancer; bioinformatic analyses
Categories
Funding
- National Natural Scientific Foundation of China [81572777, 81502558]
- Talents Introduction Projects of Liaoning Medical University
Ask authors/readers for more resources
CD44 is a well-recognized stem cell biomarker expressed in colon and gastric cancer. In order to identify whether CD44 mRNA could be used as a prognostic marker in colon and gastric cancer, bioinformatic analyses were used in this study. cBioPortal analysis and COSMIC analysis were used to explore the CD44 mutation. CD44 mRNA levels were evaluated by using SAGE Genie tools and Oncomine analysis. Kaplan-Meier Plotter was performed to identify the prognostic roles of CD44 mRNA in these two cancers. In this study, first, we found that low alteration frequency of CD44 mRNA in colon and gastric cancer. Second, the high CD44 mRNA level was found in colon and gastric cancer, and it correlated with a benign survival rate in gastric cancer. Third, CD4 and CD74 may be used as markers to predict the prognosis of colon and gastric cancer. However, the deep mechanism(s) of these results remains unclear, further studies have to be performed in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available